Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.

about

Malaria Vaccine Development: The Need for Novel Approaches: A Review Article.Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase OX40 Stimulation Enhances Protective Immune Responses Induced After Vaccination With Attenuated Malaria Parasites

P2860

Q55379631-D466CD4F-1A80-4625-8C44-07FF8E088C4C Q56342063-9B38923F-FEE7-4C9D-9B88-42DEBFE8ACD7 Q56360727-657A338D-6007-4DCC-BDA8-715DE07E546F

P2860

Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.

Item

http://www.wikidata.org/entity/Q40303478

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Efficacy of phase 3 trial of R ...... alternative development plan.

@en

type

Item

label

Efficacy of phase 3 trial of R ...... alternative development plan.

@en

prefLabel

Efficacy of phase 3 trial of R ...... alternative development plan.

@en

P1476

Efficacy of phase 3 trial of R ...... alternative development plan.

@en

P2093

Hossein Keshavarz

http://www.w3.org/2001/XMLSchema#string

Shima Mahmoudi

http://www.w3.org/2001/XMLSchema#string

P2860

A review of malaria vaccine clinical projects based on the WHO rainbow table

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

The March Toward Malaria Vaccines

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites

Malaria vaccine development and how external forces shape it: an overview.

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.

Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunities.

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.

P304

2098-2101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1295906

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28272979

http://www.w3.org/2001/XMLSchema#string

P921

malaria

phase III clinical trial

P932

5612527

http://www.w3.org/2001/XMLSchema#string

Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.

about

P2860

P2860

Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932